2026 Q3 Portfolio Activity
In 2026 Q3, TCG Crossover Management, LLC maintained a portfolio of 62 distinct positions. The most significant new addition was KORSANA BIOSCIENCES INC, now representing 4.11% of the total fund value. They heavily accumulated shares in AURA BIOSCIENCES INC, increasing the position by 6.6%. The fund also reduced its exposure to ABIVAX SA AMERICAN DEPOSITARY by 39.0%.
Position History
hover any row below to update
Loading…
Total Positions
62
Quarter
2026 Q3
Top Holding
ABVX (10.2%)
Top 10 Concentration
53.3%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 62
TCG Crossover Management, LLC Full Holdings List — 2026 Q3
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ABVX
ABIVAX SA AMERI...
|
Healthcare | 10.25% | 19.24% |
#1
Prev: #1
|
6.0 |
—
|
-2,344,796 | -39.0% |
P
S
|
3,663,038 | $362,714,023 | 2023 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CGON
CG ONCOLOGY INC
|
Healthcare | 7.35% | 6.27% |
#2
1
Prev: #3
|
5.4 |
—
|
no change | no change |
P
S
|
3,670,206 | $260,180,903 | 2024 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
AMLX
AMYLYX PHARMACE...
|
Healthcare | 5.13% | 2.70% |
#3
7
Prev: #10
|
4.1 |
—
|
no change | no change |
P
S
|
6,243,812 | $181,694,929 | 2024 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
SYRE
SPYRE THERAPEUT...
|
Healthcare | 4.78% | 4.06% |
#4
2
Prev: #6
|
3.4 |
—
|
no change | no change |
P
S
|
1,900,582 | $169,208,815 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
TNGX
TANGO THERAPEUT...
|
Healthcare | 4.77% | 6.82% |
#5
3
Prev: #2
|
2.4 |
—
|
-2,308,158 | -25.4% |
P
S
|
6,773,043 | $168,987,423 | 2022 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ZLAB
ZAI LAB LTD-ADR
|
Healthcare | 4.64% | 2.80% |
#6
3
Prev: #9
|
2.4 |
—
|
91,454 | 1.5% |
P
S
|
6,229,081 | $164,073,994 | 2021 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
IMVT
IMMUNOVANT INC
|
Healthcare | 4.25% | 4.13% |
#7
2
Prev: #5
|
2.7 |
—
|
no change | no change |
P
S
|
4,457,988 | $150,590,835 | 2022 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
DNTH
DIANTHUS THERAP...
|
Healthcare | 4.17% | 3.93% |
#8
1
Prev: #7
|
2.7 |
—
|
no change | no change |
P
S
|
1,676,624 | $147,626,743 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
KRSA
KORSANA BIOSCIE...
|
Healthcare | 4.11% | — |
#9
Prev: #—
|
5.1 |
—
|
4,549,587 | — |
NEW
|
4,549,587 | $145,586,784 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
KOD
KODIAK SCIENCES...
|
Healthcare | 3.87% | 1.35% |
#10
12
Prev: #22
|
2.5 |
—
|
no change | no change |
P
S
|
1,445,538 | $137,037,002 | 2023 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
VOR
VOR BIOPHARMA I...
|
Healthcare | 3.06% | 2.51% |
#11
2
Prev: #13
|
2.2 |
—
|
no change | no change |
P
S
|
5,673,078 | $108,242,328 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
TRAX
FIRST TRACKS BI...
|
Healthcare | 2.90% | 1.40% |
#12
9
Prev: #21
|
2.2 |
—
|
no change | no change |
P
S
|
2,895,304 | $102,609,574 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
MIRM
MIRUM PHARMACEU...
|
Healthcare | 2.70% | 2.99% |
#13
5
Prev: #8
|
3.1 |
—
|
56,918 | 5.4% |
P
S
|
1,118,967 | $95,649,299 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
BCRX
BIOCRYST PHARMA...
|
Healthcare | 2.59% | 2.65% |
#14
2
Prev: #12
|
2.0 |
—
|
no change | no change |
P
S
|
11,020,968 | $91,804,663 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
IRON
DISC MEDICINE I...
|
Healthcare | 2.48% | 2.36% |
#15
1
Prev: #16
|
2.0 |
—
|
no change | no change |
P
S
|
1,341,862 | $87,838,287 | 2024 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ADRX
ADARX PHARMACEU...
|
Healthcare | 2.32% | — |
#16
Prev: #—
|
4.4 |
—
|
4,116,452 | — |
NEW
|
4,116,452 | $82,082,053 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
COGT
COGENT BIOSCIEN...
|
Healthcare | 2.26% | 4.52% |
#17
13
Prev: #4
|
0.9 |
—
|
-2,354,433 | -48.5% |
P
S
|
2,500,003 | $80,050,096 | 2021 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
TYRA
TYRA BIOSCIENCE...
|
Healthcare | 2.15% | 2.49% |
#18
4
Prev: #14
|
2.9 |
—
|
227,000 | 7.0% |
P
S
|
3,475,980 | $76,019,683 | 2021 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
DYN
DYNE THERAPEUTI...
|
Healthcare | 2.10% | 2.46% |
#19
4
Prev: #15
|
1.8 |
—
|
no change | no change |
P
S
|
4,615,144 | $74,349,970 | 2023 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
RLAY
RELAY THERAPEUT...
|
Healthcare | 1.93% | 1.92% |
#20
3
Prev: #17
|
1.3 |
—
|
-489,827 | -11.5% |
P
S
|
3,783,529 | $68,292,698 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
AURA
AURA BIOSCIENCE...
|
Healthcare | 1.80% | 1.63% |
#21
2
Prev: #19
|
2.7 |
—
|
632,024 | 6.6% |
P
S
|
10,165,357 | $63,838,442 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
SVRA
SAVARA INC
|
Healthcare | 1.80% | 1.83% |
#22
4
Prev: #18
|
1.7 |
—
|
no change | no change |
P
S
|
12,362,205 | $63,788,978 | 2023 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
XNCR
XENCOR INC
|
Healthcare | 1.45% | 0.95% |
#23
4
Prev: #27
|
1.1 |
—
|
-396,200 | -16.2% |
P
S
|
2,055,938 | $51,295,653 | 2024 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
AVTX
AVALO THERAPEUT...
|
Healthcare | 1.31% | 1.34% |
#24
1
Prev: #23
|
1.5 |
—
|
no change | no change |
P
S
|
3,017,120 | $46,252,450 | 2024 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
GLUE
MONTE ROSA THER...
|
Healthcare | 1.27% | 2.69% |
#25
14
Prev: #11
|
1.0 |
—
|
-840,619 | -18.2% |
P
S
|
3,781,532 | $45,113,677 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
MBX
MBX BIOSCIENCES...
|
Healthcare | 1.08% | 0.86% |
#26
4
Prev: #30
|
1.4 |
—
|
no change | no change |
P
S
|
650,000 | $38,103,000 | 2024 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ENTX
ENTERA BIO LTD
|
Healthcare | 1.01% | — |
#27
Prev: #—
|
3.9 |
—
|
12,254,901 | — |
NEW
|
12,254,901 | $35,661,762 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
JANX
JANUX THERAPEUT...
|
Healthcare | 0.87% | 0.66% |
#28
7
Prev: #35
|
1.3 |
—
|
no change | no change |
P
S
|
1,789,617 | $30,924,582 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
TARS
TARSUS PHARMACE...
|
Healthcare | 0.86% | — |
#29
Prev: #—
|
3.8 |
—
|
388,164 | — |
NEW
|
388,164 | $30,513,572 | 2023 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
IPSC
CENTURY THERAPE...
|
Healthcare | 0.86% | 1.04% |
#30
5
Prev: #25
|
1.3 |
—
|
no change | no change |
P
S
|
17,754,430 | $30,360,075 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
OBX
OBSIDIAN THERAP...
|
Healthcare | 0.85% | — |
#31
Prev: #—
|
3.8 |
—
|
2,196,138 | — |
NEW
|
2,196,138 | $30,152,975 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
PHVS
PHARVARIS BV
|
Healthcare | 0.85% | 0.84% |
#32
1
Prev: #31
|
0.8 |
—
|
-60,685 | -6.0% |
P
S
|
947,544 | $30,056,096 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
LBRX
LB PHARMACEUTIC...
|
Healthcare | 0.83% | 1.13% |
#33
9
Prev: #24
|
0.3 |
—
|
-682,260 | -47.1% |
P
S
|
765,050 | $29,362,619 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
EDIT
EDITAS MEDICINE...
|
Healthcare | 0.81% | 0.87% |
#34
5
Prev: #29
|
1.3 |
—
|
no change | no change |
P
S
|
11,111,111 | $28,555,555 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
TECX
TECTONIC THERAP...
|
Healthcare | 0.79% | 1.00% |
#35
9
Prev: #26
|
1.3 |
—
|
no change | no change |
P
S
|
1,204,891 | $28,061,911 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
IFRX
INFLARX N V
|
Healthcare | 0.74% | 0.78% |
#36
3
Prev: #33
|
1.3 |
—
|
no change | no change |
P
S
|
14,500,000 | $26,100,000 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CATX
PERSPECTIVE THE...
|
Healthcare | 0.61% | 0.65% |
#37
1
Prev: #36
|
1.2 |
—
|
no change | no change |
P
S
|
7,915,567 | $21,767,809 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
AGMB
AGOMAB THERAPEU...
|
Healthcare | 0.57% | 0.64% |
#38
1
Prev: #37
|
0.7 |
—
|
-232,402 | -11.3% |
P
S
|
1,820,831 | $20,211,224 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
SLN
SILENCE THERAPE...
|
Healthcare | 0.56% | 0.80% |
#39
7
Prev: #32
|
0.2 |
—
|
-1,214,525 | -40.0% |
P
S
|
1,819,035 | $19,882,053 | 2022 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ALEC
ALECTOR INC
|
Healthcare | 0.52% | 0.48% |
#40
Prev: #40
|
1.2 |
—
|
no change | no change |
P
S
|
10,000,000 | $18,500,000 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
BHVN
BIOHAVEN LTD
|
Healthcare | 0.48% | 0.64% |
#41
3
Prev: #38
|
0.2 |
—
|
-517,529 | -29.1% |
P
S
|
1,262,423 | $16,853,347 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
MNPR
MONOPAR THERAPE...
|
Healthcare | 0.46% | 0.45% |
#42
Prev: #42
|
0.7 |
—
|
-1,085 | -0.5% |
P
S
|
202,242 | $16,112,620 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ADCT
ADC THERAPEUTIC...
|
Healthcare | 0.39% | 0.29% |
#43
1
Prev: #44
|
1.2 |
—
|
no change | no change |
P
S
|
11,390,175 | $13,896,014 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
TRDA
ENTRADA THERAPE...
|
Healthcare | 0.19% | 0.19% |
#44
2
Prev: #46
|
1.1 |
—
|
no change | no change |
P
S
|
1,060,230 | $6,732,461 | 2021 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CGEM
CULLINAN THERAP...
|
Healthcare | 0.18% | 0.18% |
#45
2
Prev: #47
|
1.1 |
—
|
no change | no change |
P
S
|
406,786 | $6,244,165 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
AGEN
AGENUS INC
|
Healthcare | 0.17% | — |
#46
Prev: #—
|
3.6 |
—
|
603,892 | — |
NEW
|
603,892 | $5,996,648 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
OCUL
OCULAR THERAPEU...
|
Healthcare | 0.16% | 0.39% |
#47
4
Prev: #43
|
0.1 |
—
|
-927,429 | -56.3% |
P
S
|
720,323 | $5,524,877 | 2024 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ARVN
ARVINAS INC
|
Healthcare | 0.15% | 0.14% |
#48
Prev: #48
|
1.1 |
—
|
no change | no change |
P
S
|
707,098 | $5,469,403 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
KRRO
KORRO BIO INC
|
Healthcare | 0.12% | 0.13% |
#49
Prev: #49
|
1.0 |
—
|
no change | no change |
P
S
|
416,301 | $4,125,543 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
N/A
RESEARCH ALLIAN...
|
|
Unknown | 0.10% | — |
#50
Prev: #—
|
3.5 |
—
|
300,000 | — |
NEW
|
300,000 | $3,600,000 | — | 13F Filing | 2026-09-30 | 2026-11-16 |
Showing 1-50 of 62 holdings